Analyst Ranking
Top 12%
#584 out of 5185 analysts
Average Return
+10.12%
Win Rate
57%69 out of 122
Risk vs Reward
Poor
Good

Catherine Schulte's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Nanostring Technologies IncNSTGQ
+172.99%$25.14$68.63
2020-04-07 -
2021-04-07
Buy
Exact Sciences CorpEXAS
+117.49%$44.37$96.50
2018-02-27 -
2019-02-27
Buy
Castle Biosciences IncCSTL
+112.13%$28.27$59.97
2020-03-27 -
2021-03-26
Buy
Nanostring Technologies IncNSTGQ
+106.07%$14.00$28.85
2018-06-04 -
2019-06-04
Buy
Exact Sciences CorpEXAS
+98.53%$51.55$102.34
2025-05-02 -
2026-01-30
Buy

Catherine Schulte Analyst Color

Get additional color on Catherine Schulte's coverage of popular stocks

Catherine Schulte's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Agilent Technologies IncA
19Buy$165.00+23.27%Maintains
2 months ago
Exact Sciences CorpEXAS
13Buy$88.00-14.01%Maintains
3 months ago
Avantor IncAVTR
14Buy$17.00+55.68%Maintains
3 months ago
Mettler Toledo International IncMTD
10Hold$1,230.00-10.43%Maintains
6 months ago
Thermo Fisher Scientific IncTMO
25Buy$567.00-2.01%Maintains
6 months ago
Danaher CorpDHR
11Buy$229.00+4.62%Maintains
6 months ago
Maravai Lifesciences Holdings IncMRVI
6Hold$2.00-40.48%Maintains
9 months ago
Qiagen NvQGEN
4Hold$43.00-19.88%Maintains
9 months ago
Bio Techne CorpTECH
11Hold$68.00+6.10%Downgrades
a year ago
Revvity IncRVTY
5Buy$165.00N/AMaintains
3 years ago
Castle Biosciences IncCSTL
4Buy$38.00N/AMaintains
3 years ago
Twist Bioscience CorpTWST
2Buy$33.00N/AMaintains
3 years ago
Biora Therapeutics IncBIOR
1Hold$2.00N/ADowngrades
5 years ago
Chembio Diagnostics IncCEMI
1Buy$21.00N/AInitiates Coverage On
6 years ago
Illumina IncILMN
4Hold$310.00N/ADowngrades
6 years ago
Nanostring Technologies IncNSTGQ
5Buy$29.00N/AMaintains
6 years ago
Waters CorpWAT
5Hold$211.00N/ADowngrades
7 years ago
Natera IncNTRA
1Buy$20.00N/AMaintains
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.